DFCM
JANX icon

Dark Forest Capital Management’s Janux Therapeutics JANX Stock Holding History

Dark Forest Capital Management’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-57,363
Closed -$792K – 967
2025
Q4 		$792K Buy
57,363
+33,716
+143% +$793K 0.04% 711
2025
Q3 		$578K Sell
23,647
-23,209
-50% -$565K 0.02% 889
2025
Q2 		$1.08M Buy
46,856
+2,184
+5% +$57.5K 0.04% 714
2025
Q1 		$1.21M Buy
+44,672
New +$1.68M 0.05% 598

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dark Forest Capital Management's JANX Position: Q1 2026 in Review

Dark Forest Capital Management sold out of Janux Therapeutics (JANX) in Q1 2026, closing a stake of 57,363 shares — an estimated $792K sold.

Dark Forest Capital Management first reported a position in JANX in Q1 2025 and held it in 4 quarters. The position peaked at $1.21M in Q1 2025. 190 funds tracked by Wall St. Rank hold JANX as of Q1 2026.

  • Dark Forest Capital Management reported no remaining Janux Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 57,363 Janux Therapeutics shares in Q1 2026, an estimated $792K.
  • Dark Forest Capital Management first reported a position in Janux Therapeutics in Q1 2025 and held it in 4 quarters.
  • Dark Forest Capital Management's Janux Therapeutics position peaked at $1.21M in Q1 2025.
  • 190 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.